Orivas   Report issue

For profit Phase 4
Founded: Vilnius Lithuania (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2016
NCT02999217
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Orivas, Lithuania